Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Novel analgesic agents imparted in recent patent literature

July 3, 2007

Promising data from arimoclomol open-label extension trial in ALS reported

July 3, 2007

SkyePharma licenses SKP-1041 to Somnus Therapeutics

July 3, 2007

FDA approves YM BioSciences' IND for AeroLEF for severe pain

July 3, 2007

Vyvanse filed for ADHD in adults

July 2, 2007

Organon signs asset purchase agreement for Kadmus' FAAH technology

July 2, 2007

Acadia initiates phase IIb trial of ACP-104 for schizophrenia

July 2, 2007

Roche and Merck & Co. patents report new agents for depression, psychosis and sleep disorders

July 2, 2007

New formulation of Rebif recommended for European approval

June 29, 2007

Phase II program begins for sufentanil patch

June 29, 2007

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...